Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity (2016 - 2025)

cbdMD (YCBD) has disclosed Common Equity for 10 consecutive years, with $9.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 405.61% to $9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, up 405.61% year-over-year, with the annual reading at $7.2 million for FY2025, 268.04% up from the prior year.
  • Common Equity hit $9.0 million in Q4 2025 for cbdMD, up from $7.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $103.1 million in Q3 2021 to a low of $665798.0 in Q1 2025.
  • Historically, Common Equity has averaged $32.4 million across 5 years, with a median of $17.4 million in 2023.
  • Biggest five-year swings in Common Equity: plummeted 88.23% in 2024 and later skyrocketed 405.61% in 2025.
  • Year by year, Common Equity stood at $84.4 million in 2021, then crashed by 68.49% to $26.6 million in 2022, then plummeted by 73.54% to $7.0 million in 2023, then plummeted by 74.68% to $1.8 million in 2024, then surged by 405.61% to $9.0 million in 2025.
  • Business Quant data shows Common Equity for YCBD at $9.0 million in Q4 2025, $7.2 million in Q3 2025, and $6.1 million in Q2 2025.